Ondansetron 8mg orodispersible tablets for prevention of chemotherapy and post-op nausea.
Setronomet 8mg Oral Dispersible Tablet is indicated for the prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy and radiotherapy, and for the prevention of postoperative nausea and/or vomiting. Not indicated for the treatment of children less than 4 years old.
Attributes
Product Content
How to Use:
• Dosage and administration should be described by the physician
• Not indicated for children less than 4 years old
The link to Setronomet 8mg 4 OroDispersible Tablet has been copied